DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Diphenhydramine hydrochlorideis the generic ingredient in seventeen branded drugs marketed by Mcneil Cons, Alra, Anabolic, Elkins Sinn, Fosun Pharma, Halsey, Heather, Heritage Pharma, Hikma Intl Pharms, Impax Labs, Ivax Sub Teva Pharms, Lannett, Lederle, LNK, Mk Labs, Mutual Pharm, Newtron Pharms, Nexgen Pharma Inc, Perrigo, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Superpharm, Teva, Valeant Pharm Intl, Vangard, Watson Labs, Whiteworth Town Plsn, Cenci, Usl Pharma, Bundy, Kv Pharm, Naska, Pharm Assoc, Alpharma Us Pharms, App Pharms, Bel Mar, Dr Reddys, Eurohlth Intl Sarl, Hospira, Lyphomed, Micro Labs, Mylan Institutional, West-ward Pharms Int, Wyeth Ayerst, Abraxis Pharm, Fresenius Kabi Usa, Intl Medication, Parke Davis, Morton Grove, Cumberland Swan, Hi Tech Pharma, Lannett Co Inc, Warner Chilcott, Glaxosmithkline, Aurobindo Pharma Ltd, Bionpharma Inc, Strides Pharma, Bayer Hlthcare, Amneal Pharms Co, Apotex, P And L, and Perrigo R And D, and is included in ninety-eight NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
There are twenty-three drug master file entries for diphenhydramine hydrochloride. Sixteen suppliers are listed for this compound.
Summary for diphenhydramine hydrochloride
|Drug Master File Entries:||23|
|Suppliers / Packagers:||16|
|Bulk Api Vendors:||100|
|Formulation / Manufacturing:||see details|
|Drug Sales Revenues:||Drug sales revenues for diphenhydramine hydrochloride|
|DailyMed Link:||diphenhydramine hydrochloride at DailyMed|
Pharmacology for diphenhydramine hydrochloride
|Drug Class||Histamine-1 Receptor Antagonist |
|Mechanism of Action||Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for diphenhydramine hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Perrigo||ANTITUSSIVE||diphenhydramine hydrochloride||SYRUP;ORAL||071292-001||Apr 10, 1987||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Anabolic||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||CAPSULE;ORAL||083275-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Perrigo R And D||NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride; naproxen sodium||TABLET;ORAL||208499-001||May 10, 2019||OTC||No||No||Start Trial||Start Trial||Start Trial|
|Nexgen Pharma Inc||DIPHENHYDRAMINE HYDROCHLORIDE||diphenhydramine hydrochloride||CAPSULE;ORAL||083634-001||Approved Prior to Jan 1, 1982||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.